@FiercePharma: Zoetis R&D chief Catherine Knupp on the fight to stay atop animal health. FierceAnimalHealth article | Follow @FiercePharma
@CarlyHFierce: UPDATED with a statement from $NVS - Novartis flu vaccine under the lens as Italy probes 13 deaths. Article | Follow @CarlyHFierce
> Novartis ($NVS) reports that Gilenya failed to outperform a placebo in patients with primary-progressive multiple sclerosis. Story
> GlaxoSmithKline ($GSK) fired an executive who complained about discrimination in the company's South African unit when he failed to appear for a performance plan. Story
> Gilead Sciences ($GILD) has given generics maker Mylan nonexclusive rights to manufacture in 112 countries cheaper versions of an investigational HIV med, assuming it is approved. Story
> AbbVie ($ABBV) has agreed to donate to the non-profit Medicines Patent Pool (MPP), two HIV meds approved for children. Story
> Pfizer ($PFE) has completed its $635 million buyout of the marketed vaccines portfolio of Baxter International ($BAX). Release
> The European Commission has approved Boehringher Ingelheim's Vargatef (nintedanib) in combination with docetaxal for use in adult patients with locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) after first-line chemotherapy. Story
Medical Device News
@FierceMedDev: ICYMI: U.K. and Wellcome Trust back trial of new, 15-minute Ebola test in West Africa. FierceDiagnostics article | Follow @FierceMedDev
@EmilyWFierce: Merck KGaA will hold onto its consumer health biz--for now. FiercePharma story | Follow @EmilyWFierce
> Harvard researchers using 3-D printing to create customized airway stents. Report
> Philips to focus on informatics as part of HealthTech restructure. Story
> Study shows artificial pancreas improves treatment for Type 1 diabetes. Article
Biotech News
@FierceBiotech: After numerous setbacks, $LLY mounts another pivotal assault on Alzheimer's. More | Follow @FierceBiotech
@JohnCFierce: Takeda gets a BTD designation on ixazomib (MLN9708), for the treatment of relapsed or refractory systemic light-chain (AL) amyloidosis. | Follow @JohnCFierce
@DamianFierce: In which hackers trick bankers into tipping them off to biopharma buyouts. Story | Follow @DamianFierce
> Fresh from a $3.85B deal, biotech CEO sets sights on the next big thing. Story
> Top research institutions hand hot gene-editing tech--with a catch--to Editas. More
> Buzz: Deep job cuts looming at GlaxoSmithKline's U.S. ops in RTP, Philly. Article
> As PDUFA looms Sanofi punts a $35M partnership. Item
CRO News
> Almac partners up to keep patients--and data--safe in trial emergencies. More
> WuXi pairs up with deCODE spinout to further its genomics expansion. News
> GVK gets its drug repurposing tech into Japan with new partnership. Story
> Quintiles pools postmarketing services into a single offering. Item
> Accovion reaches into France amid expansion kick. Article
Biotech IT News
> U.K. heavyweights commit $16M to Oxford Uni genome data analysis spinout. Report
> Texas' $3B cancer agency makes computational biology a priority. News
> Nvidia backs projects to tap GPUs for cancer research. Story
> Humana agrees to contribute information to PearlDiver's database. Article
> Monocl Software bags grant for KOL assessment platform. More
Animal Health News
> Bayer launches smartphone app to help farmers monitor dairy herd health. Story
> Natura Pet issues 8-state voluntary recall of cat food; Canada included. More
> IDEXX aids in discovery of new biomarker to spot early kidney disease in cats. Item
> Dutch set safety corridor as a bird flu hits a fourth poultry farm. News
> Nova Scotia establishes program to support beef industry and safety standards. Article